"Teneligliptin and “Thorough QTc study”: thorough enough?." Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, , pp. 1141–1142
Disclosure
The author has no conflicts of interest to declare in this communication.
Open access
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.
Register now or learn more